Literature DB >> 8855263

p53-dependent cell cycle arrest induced by N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal in platelet-derived growth factor-stimulated human fibroblasts.

C Dietrich1, T Bartsch, F Schanz, F Oesch, R J Wieser.   

Abstract

Proteases are known to play important roles in cell growth control, although the underlying mechanisms are still poorly understood. Here we show that the protease inhibitor N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal induced cell cycle arrest in platelet-derived growth factor-stimulated human fibroblasts at the G1/S boundary of the cell cycle by inhibiting the proteasome. Inhibition of the proteasome resulted in accumulation of the tumor suppressor p53, which was followed by an increase in the amount of the cyclin-dependent kinase-inhibitor p21. As a consequence, both phosphorylation and activity of the cyclin-dependent kinase 2/cyclin E complex were inhibited. We further observed that the retinoblastoma gene product, pRb, remained in the hypophosphorylated state, thus preventing cells from progression into the S-phase. These studies strongly support the hypothesis that the proteasome is a key regulator in the G1-phase of cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8855263      PMCID: PMC38238          DOI: 10.1073/pnas.93.20.10815

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment.

Authors:  S Mittnacht; R A Weinberg
Journal:  Cell       Date:  1991-05-03       Impact factor: 41.582

2.  In vivo ubiquitination and proteasome-mediated degradation of p53(1).

Authors:  C G Maki; J M Huibregtse; P M Howley
Journal:  Cancer Res       Date:  1996-06-01       Impact factor: 12.701

3.  The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element.

Authors:  J A DeCaprio; J W Ludlow; D Lynch; Y Furukawa; J Griffin; H Piwnica-Worms; C M Huang; D M Livingston
Journal:  Cell       Date:  1989-09-22       Impact factor: 41.582

4.  Involvement of plasma membrane glycoproteins in the contact-dependent inhibition of growth of human fibroblasts.

Authors:  R J Wieser; R Heck; F Oesch
Journal:  Exp Cell Res       Date:  1985-06       Impact factor: 3.905

5.  A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids.

Authors:  D Wessel; U I Flügge
Journal:  Anal Biochem       Date:  1984-04       Impact factor: 3.365

6.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.

Authors:  M Scheffner; B A Werness; J M Huibregtse; A J Levine; P M Howley
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

7.  Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2.

Authors:  J R Bischoff; P N Friedman; D R Marshak; C Prives; D Beach
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

8.  Cyclin is degraded by the ubiquitin pathway.

Authors:  M Glotzer; A W Murray; M W Kirschner
Journal:  Nature       Date:  1991-01-10       Impact factor: 49.962

9.  Thiol protease-specific inhibitor E-64 arrests human epidermoid carcinoma A431 cells at mitotic metaphase.

Authors:  Y Shoji-Kasai; M Senshu; S Iwashita; K Imahori
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

10.  Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase.

Authors:  O Aprelikova; Y Xiong; E T Liu
Journal:  J Biol Chem       Date:  1995-08-04       Impact factor: 5.157

View more
  11 in total

1.  Synthesis and calpain inhibitory activity of peptidomimetic compounds with constrained amino acids at the P2 position.

Authors:  Isaac O Donkor; Rajani Korukonda
Journal:  Bioorg Med Chem Lett       Date:  2008-07-27       Impact factor: 2.823

Review 2.  Proteasome and myogenesis.

Authors:  F Gardrat; V Montel; J Raymond; J L Azanza
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

3.  Integration of the ubiquitin-proteasome pathway with a cytosolic oligopeptidase activity.

Authors:  E W Wang; B M Kessler; A Borodovsky; B F Cravatt; M Bogyo; H L Ploegh; R Glas
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

Review 4.  Proteasome inhibition: a new strategy in cancer treatment.

Authors:  J Adams; V J Palombella; P J Elliott
Journal:  Invest New Drugs       Date:  2000-05       Impact factor: 3.850

5.  Preferential induction of apoptosis for primary human leukemic stem cells.

Authors:  Monica L Guzman; Carol F Swiderski; Dianna S Howard; Barry A Grimes; Randall M Rossi; Stephen J Szilvassy; Craig T Jordan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-25       Impact factor: 11.205

6.  Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein.

Authors:  J Roth; M Dobbelstein; D A Freedman; T Shenk; A J Levine
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

7.  p53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitors.

Authors:  Duonan Yu; Martin Carroll; Andrei Thomas-Tikhonenko
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

8.  Proteasome inhibition suppresses essential immune functions of human CD4+ T cells.

Authors:  Carsten Berges; Heinrich Haberstock; Dominik Fuchs; Marion Miltz; Mahmoud Sadeghi; Gerhard Opelz; Volker Daniel; Cord Naujokat
Journal:  Immunology       Date:  2008-01-23       Impact factor: 7.397

9.  Inactivation of p53 but not p73 by adenovirus type 5 E1B 55-kilodalton and E4 34-kilodalton oncoproteins.

Authors:  J Roth; C König; S Wienzek; S Weigel; S Ristea; M Dobbelstein
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  Differential p38-dependent signalling in response to cellular stress and mitogenic stimulation in fibroblasts.

Authors:  Dagmar Faust; Christina Schmitt; Franz Oesch; Barbara Oesch-Bartlomowicz; Ilona Schreck; Carsten Weiss; Cornelia Dietrich
Journal:  Cell Commun Signal       Date:  2012-03-09       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.